CLINICAL_TRIALS
ClinicalTrials.gov record update
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03384316
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:02.155125+00:00
- Published At
- 2019-12-23T00:00:00+00:00
- Record Updated At
- 2020-09-09
- Results Posted At
- 2019-12-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Neoplasms", "Prostate Cancer", "Lung Cancer", "Breast Cancer", "Colon Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-09-09"- protocolSection.identificationModule.nctId
"NCT03384316"- protocolSection.identificationModule.officialTitle
"Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-12-23"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.